journal article·2026-02Open access

Tubule‐Derived IFN‐α Promotes GSDMD‐Mediated Macrophage Pyroptosis to Drive Renal Inflammation and Fibrosis Through JAK2/STAT2 Activation

Yiping Xu, Yating Wang, Siming Jiang, Yi Li, Guanglan Li, Yuchu Liu, Siyuan Li, Yiming Zhou, Qinghua Liu, Yi Zhou, Wei Chen, Hongyu Li, Haiping Mao

Advanced Science· Volume 13· Issue 11

Abstract

Abstract Macrophages exhibit high plasticity in response to tubular epithelial cell (TEC) injury. Gasdermin D (GSDMD)‐mediated pyroptosis amplifies the inflammatory and fibrogenic cascade, yet its role in chronic kidney disease (CKD) remains elusive. Herein, GSDMD is upregulated in kidney macrophages following unilateral renal ischemia‐reperfusion injury (UIRI) or folic acid‐induced injury, paralleling elevated pyroptosis rates. Clinically, the active fragment GSDMD‐N localizes primarily to CD68⁺ macrophages, and its renal level positively correlates with fibrosis severity across diverse CKD etiologies, reinforcing its pathogenic relevance. Macrophage‐specific deletion of Gsdmd ameliorates pyroptosis, inflammation, and renal fibrosis in both murine models, without affecting acute tubular damage in bilateral IRI. Mechanistically, injured TECs initiate this cascade through secreted IFN‐α, which activates the IFNAR1/JAK2/STAT2 axis in macrophages​. STAT2 then forms a complex with IRF9, directly binding to the Gsdmd promoter to transcriptionally upregulate GSDMD expression. Genetic ablation of Jak2 , Stat2 , or Ifnar1 reduces GSDMD and GSDMD‐N levels and inhibits IL‐1β/IL‐18 secretion. Notably, administration of an IFN‐α neutralizing antibody attenuates UIRI‐induced pyroptotic macrophage, inflammation, and renal fibrosis. Collectively, the findings uncover a STAT2/IRF9‐dependent paracrine IFN‐α feedback loop that orchestrates GSDMD‐mediated pyroptosis, linking injured TECs to macrophage‐driven renal inflammation and fibrosis. Targeting this axis represents a promising strategy to halt CKD progression.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Inflammasome and immune disorders · Acute Kidney Injury Research · Nephrotoxicity and Medicinal Plants

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Nephrology The First Affiliated Hospital Sun Yat‐sen University Guangzhou 510080 China

Department of Nephrology NHC Key Laboratory of ClinicalNephrology (Sun Yat-Sen University) and Guangdong Provincial Key Laboratory ofNephrology Guangzhou 510080 China

Basic andTranslational Medical Research Center, Sun Yat-sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Guangdong Province

References (57)

Show source-provided references
1. 10.1016/S2214-109X(23)00570-310.1016/S2214-109X(23)00570-3 ↗
2. 10.1038/s41581-019-0248-y10.1038/s41581-019-0248-y ↗
3. 10.1038/s41392-023-01379-710.1038/s41392-023-01379-7 ↗
4. 10.1038/s41581-019-0110-210.1038/s41581-019-0110-2 ↗
5. 10.1002/advs.20230975210.1002/advs.202309752 ↗
6. 10.1111/j.1523-1755.2005.00422.x10.1111/j.1523-1755.2005.00422.x ↗
7. 10.1681/ASN.201305052810.1681/ASN.2013050528 ↗
8. 10.1038/s41467-024-47315-310.1038/s41467-024-47315-3 ↗
9. 10.1161/HYPERTENSIONAHA.121.1875010.1161/HYPERTENSIONAHA.121.18750 ↗
10. 10.1038/s41467-021-27034-910.1038/s41467-021-27034-9 ↗
11. 10.1038/s41573-021-00154-z10.1038/s41573-021-00154-z ↗
12. 10.1038/s41419-023-06005-610.1038/s41419-023-06005-6 ↗
13. 10.1016/j.smim.2023.10178110.1016/j.smim.2023.101781 ↗
14. 10.1038/s41419-022-04910-w10.1038/s41419-022-04910-w ↗
15. 10.1038/s41590-023-01526-w10.1038/s41590-023-01526-w ↗
16. 10.1038/s41577-019-0165-010.1038/s41577-019-0165-0 ↗
17. 10.1016/j.apsb.2021.10.00610.1016/j.apsb.2021.10.006 ↗
18. 10.1038/s41419-020-2323-510.1038/s41419-020-2323-5 ↗
19. 10.1161/ATVBAHA.123.32061210.1161/ATVBAHA.123.320612 ↗
20. 10.1038/s41419-022-05138-410.1038/s41419-022-05138-4 ↗
21. 10.7150/thno.7229110.7150/thno.72291 ↗
22. 10.1038/s41467-023-36614-w10.1038/s41467-023-36614-w ↗
23. 10.1016/j.cell.2024.10.01010.1016/j.cell.2024.10.010 ↗
24. 10.1681/ASN.201901006810.1681/ASN.2019010068 ↗
25. 10.1038/nature1344910.1038/nature13449 ↗
26. 10.1038/s41586-021-03341-510.1038/s41586-021-03341-5 ↗
27. 10.1073/pnas.171842611510.1073/pnas.1718426115 ↗
28. 10.1038/s41467-019-10970-y10.1038/s41467-019-10970-y ↗
29. 10.1016/j.cell.2022.09.02310.1016/j.cell.2022.09.023 ↗
30. 10.1038/s41392-023-01468-710.1038/s41392-023-01468-7 ↗
31. 10.1152/ajprenal.00487.201210.1152/ajprenal.00487.2012 ↗
32. 10.1038/s41423-019-0343-910.1038/s41423-019-0343-9 ↗
33. 10.1038/s41392-024-01958-210.1038/s41392-024-01958-2 ↗
34. 10.2147/JIR.S48855310.2147/JIR.S488553 ↗
35. 10.1038/s41586-024-08022-710.1038/s41586-024-08022-7 ↗
36. 10.1016/j.jdermsci.2022.12.00610.1016/j.jdermsci.2022.12.006 ↗
37. 10.1016/j.immuni.2017.11.01310.1016/j.immuni.2017.11.013 ↗
38. 10.1038/s41420-022-00894-w10.1038/s41420-022-00894-w ↗
39. 10.1016/j.cell.2024.11.01810.1016/j.cell.2024.11.018 ↗
40. 10.1038/s41418-021-00755-610.1038/s41418-021-00755-6 ↗
41. 10.1681/ASN.201608084010.1681/ASN.2016080840 ↗
42. 10.1681/ASN.201708086310.1681/ASN.2017080863 ↗
43. 10.1016/j.immuni.2005.01.00510.1016/j.immuni.2005.01.005 ↗
44. 10.1038/cr.2013.4710.1038/cr.2013.47 ↗
45. 10.1038/s41590-024-01804-110.1038/s41590-024-01804-1 ↗
46. 10.1681/ASN.000000057710.1681/ASN.0000000577 ↗
47. 10.1093/cvr/cvae11710.1093/cvr/cvae117 ↗
48. 10.1016/j.intimp.2024.11349810.1016/j.intimp.2024.113498 ↗
49. 10.3389/fimmu.2024.148920510.3389/fimmu.2024.1489205 ↗
50. 10.3389/fphar.2022.104668710.3389/fphar.2022.1046687 ↗
51. 10.1016/j.immuni.2024.09.00410.1016/j.immuni.2024.09.004 ↗
52. 10.1016/j.kint.2024.04.01610.1016/j.kint.2024.04.016 ↗
53. 10.1002/advs.20230691210.1002/advs.202306912 ↗
54. 10.1016/j.kint.2019.04.03510.1016/j.kint.2019.04.035 ↗
55. 10.1158/0008-5472.CAN-22-119910.1158/0008-5472.CAN-22-1199 ↗
56. 10.1016/j.xpro.2020.10024610.1016/j.xpro.2020.100246 ↗
57. 10.1002/advs.20230060410.1002/advs.202300604 ↗